Madorra Therapeutic Device
Moderate to Severe Vulvovaginal Atrophy (Vaginal Dryness)
Pre-clinicalActive
Key Facts
Indication
Moderate to Severe Vulvovaginal Atrophy (Vaginal Dryness)
Phase
Pre-clinical
Status
Active
Company
About Madorra
Madorra is a private, pre-revenue medical device company founded in 2014 and headquartered in Portland, Oregon. The company is developing a novel, nonhormonal device for the treatment of moderate to severe vulvovaginal atrophy (vaginal dryness), a condition prevalent in post-menopausal women and breast cancer survivors. It has received Breakthrough Device Designation from the FDA for its technology, indicating significant potential to address an unmet need. Madorra is led by an experienced team with backgrounds in medical devices and women's health, and is backed by notable venture capital firms.
View full company profile